We show that mesenchymal-like GBM neurospheres enriched with GSCs (mGSCs) express high levels of TGFBR2 and are capable of repressing CD4+ and CD8+ T cell viability and function in vitro. The gene discussed is TGFBR2; the disease is glioblastoma.